Author

Olaf Heidenreich

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1

Frequent Co-Authors

Anja Krippner-Heidenreich· 1 shared Annelisa M. CorneliD· 1 shared Ester Dunnebach· 1 shared Farnaz BarnehiD· 1 shared Gertjan J.L. Kaspers· 1 shared Jacqueline Cloos· 1 shared Joost B. KoedijkiD· 1 shared Jürgen Kuball· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anja Krippner-Heidenreich

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia

Farnaz Barneh, Joost B. Koedijk, Noa E. Wijnen, Tom Meulendijks, Minoo Ashtiani, Ester Dunnebach, Noël Dautzenberg, Annelisa M. Cornel, Anja Krippner-Heidenreich, Kim Klein, Michel C. Zwaan, Jürgen Kuball, Stefan Nierkens, Jacqueline Cloos, Gertjan J.L. Kaspers, Olaf Heidenreich

This study evaluates CD19 expression in pediatric AML and shows that CD19-directed immunotherapies are effective against CD19+ AML, similar to their efficacy in BCP-ALL.

bioRxiv · Apr 19, 2024Immunology